A systematic review of primary active surveillance management of low-risk papillary carcinoma

被引:19
|
作者
Alhashemi, Ahmad [1 ]
Goldstein, David P. [2 ,3 ]
Sawka, Anna M. [1 ,4 ]
机构
[1] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
[4] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada
关键词
active surveillance; papillary thyroid cancer; thyroid carcinoma; thyroidectomy; DIFFERENTIATED THYROID-CARCINOMA; THERAPEUTIC STRATEGY; ENDOCRINE SURGEONS; SURGICAL-TREATMENT; JAPANESE SOCIETY; UNITED-STATES; PATIENT AGE; CANCER; MICROCARCINOMA; ASSOCIATION;
D O I
10.1097/CCO.0000000000000244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Active surveillance is close follow-up of neoplasms, with predetermined intervention triggers. We systematically reviewed the published English language literature on primary active surveillance of low-risk papillary thyroid cancer (PTC). Recent findings We searched seven electronic databases (1980-2015), supplemented with a hand search. Two reviewers independently screened 1715 citations and reviewed 32 full-text papers, ultimately including two papers. Data were independently abstracted. There were two Japanese single-center, single-arm studies reporting on 1235 and 322 patients with PTC microcarcinoma (primary <1 cm in diameter) confined to the thyroid. Mean study follow-up was of 5.0 and 6.5 years, respectively. Disease triggers for thyroidectomy included progression of the primary tumor or incident metastatic disease. The rates of thyroidectomy were 15.5% (191/1235) and 8.7% (28/322) in respective studies. The incidence of primary tumor enlargement >= 3 mm in maximal diameter was 4.6% (58/1235) and 5.0% (16/322). The incidence of nodal metastases was 1.5% (19/1235) and 0.9% (3/322). There were neither reports of PTC-related death nor development of distant metastatic disease. Quality of life, psychosocial health, and economic outcomes were not reported. Summary In two Japanese single-arm studies, active surveillance of PTC microcarcinoma was relatively well tolerated; however, more long-term outcome research is needed.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [31] BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
    Kim, Kyeong J.
    Kim, Sin G.
    Tan, Jie
    Shen, Xiaopei
    Viola, David
    Elisei, Rossella
    Puxeddu, Efisio
    Fugazzola, Laura
    Colombo, Carla
    Jarzab, Barbara
    Czarniecka, Agnieszka
    Lam, Alfred K.
    Mian, Caterina
    Vianello, Federica
    Yip, Linwah
    Riesco-Eizaguirre, Garcilaso
    Santisteban, Pilar
    O'Neill, Christine J.
    Sywak, Mark S.
    Clifton-Bligh, Roderick
    Bendlova, Bela
    Sykorova, Vlasta
    Xing, Mingzhao
    EUROPEAN JOURNAL OF CANCER, 2020, 124 : 161 - 169
  • [32] Active Surveillance for Low-Risk Thyroid Cancers: A Review of Current Practice Guidelines
    Kim, Min Joo
    Moon, Jae Hoon
    Lee, Eun Kyung
    Song, Young Shin
    Jung, Kyong Yeun
    Lee, Ji Ye
    Kim, Ji-hoon
    Kim, Kyungsik
    Park, Sue K.
    Park, Young Joo
    ENDOCRINOLOGY AND METABOLISM, 2024, 39 (01) : 47 - 60
  • [33] Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea
    Lee, Eun Kyung
    Moon, Jae Hoon
    Hwangbo, Yul
    Ryu, Chang Hwan
    Cho, Sun Wook
    Choi, June Young
    Chung, Eun-Jae
    Jeong, Woo-Jin
    Jung, Yuh-Seog
    Ryu, Junsun
    Kim, Su-jin
    Kim, Min Joo
    Kim, Yeo Koon
    Lee, Chang Yoon
    Lee, Ji Ye
    Yu, Hyeong Won
    Hah, Jeong Hun
    Lee, Kyu Eun
    Lee, You Jin
    Park, Sue K.
    Park, Do Joon
    Kim, Ji-hoon
    Park, Young Joo
    THYROID, 2022, 32 (11) : 1328 - 1336
  • [34] Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status
    Yamamoto, Masashi
    Miyauchi, Akira
    Ito, Yasuhiro
    Fujishima, Makoto
    Sasaki, Takahiro
    Kudo, Takumi
    THYROID, 2023, 33 (10) : 1182 - 1189
  • [35] Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study
    Sawka, Anna M.
    Ghai, Sangeet
    Rotstein, Lorne
    Irish, Jonathan C.
    Pasternak, Jesse D.
    Monteiro, Eric
    Chung, Janet
    Zahedi, Afshan
    Su, Jie
    Xu, Wei
    Jones, Jennifer M.
    Gafni, Amiram
    Baxter, Nancy N.
    Goldstein, David P.
    THYROID, 2024, 34 (05) : 626 - 634
  • [36] Re: "Active surveillance of low-risk papillary thyroid cancer: A meta-analysis"
    Cho, Se Jin
    Baek, Jung Hwan
    SURGERY, 2020, 167 (05) : 885 - +
  • [37] Oncological safety of active surveillance for low-risk ductal carcinoma in situ — a systematic review and meta-analysis
    Matthew G. Davey
    Aoife J. Lowery
    Michael J. Kerin
    Irish Journal of Medical Science (1971 -), 2023, 192 : 1595 - 1600
  • [38] Comparison of Postoperative Unfavorable Events in Patients with Low-Risk Papillary Thyroid Carcinoma: Immediate Surgery Versus Conversion Surgery Following Active Surveillance
    Sasaki, Takahiro
    Miyauchi, Akira
    Fujishima, Makoto
    Ito, Yasuhiro
    Kudo, Takumi
    Noda, Takuya
    Sano, Tsutomu
    Kishi, Taketoshi
    Nakamura, Tomohiko
    THYROID, 2023, 33 (02) : 186 - 191
  • [39] Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma
    Sasaki, Takahiro
    Miyauchi, Akira
    Ito, Yasuhiro
    Kudo, Takumi
    Kanemura, Nobuaki
    Sano, Tsutomu
    Kawano, Shiori
    Yamamoto, Masatoshi
    Fujishima, Makoto
    Masuoka, Hiroo
    Higashiyama, Takuya
    Kihara, Minoru
    Miya, Akihiro
    THYROID, 2021, 31 (02) : 217 - 223
  • [40] Management of Low-Risk Papillary Thyroid Cancer
    Iniguez-Ariza, Nicole M.
    Brito, Juan P.
    ENDOCRINOLOGY AND METABOLISM, 2018, 33 (02) : 185 - 194